Clinical Trial Update: Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combination chemotherapy, radiation therapy, and RSR13 in stage III non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• RSR13 (RSR13)

Snippet

Sponsor: Spectrum Pharmaceuticals, Inc | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED